Telmisartan Upregulates the Expression of Adiponectin in Visceral Fat and Decreases Insulin Resistance

Rong LUO,Zi-qin ZHAO,Feng-shi TIAN,Xi-lan ZHENG,Hai-liang XIONG,Jin GE,Song YUE

DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2013.07.008

2013-01-01

Abstract:Objective To investigate the effects of telmisartan on insulin sensitivity and adiponectinexpression in primary cultured human preadipocytes and adipose tissue of spontaneously type 2 diabetic OLETF rats fed with high-fat diet.Methods Human subcutaneous and visceral preadipocytes were differentiated for 14 days in serum-free medium,in the presence of 10 μmol/L telmisartan (group H-T),or pioglitazone (group H-P),or vehicle (group H-N).Insulin sensitivity of preadipocytes was detected by glucose consumption test.Radioimmunoassay was employed to determine the concentration of adiponectin in the culture medium.The mRNA expression of adiponectin was measured by real-time fluorescence quantitative polymerase chain reaction (real-time PCR) with TaqMan probe.From 22 weeks of age,the prediabetic OLETF rats,which were fed with high-fat diet from 8 weeks old,were divided into group O-HFD,O-T (treated with telmisartan 5 mg · kg-1 · day-1),or O-P (treated with pioglitazone 10 mg · kg-1 ·day-1).The insulin resistance of OLETF rats were determined by euglycaemic-hyperinsulinaemic clamp test and oral glucose tolerance test (OGTT).The mRNA and protein expression of adiponectin in the subcutaneous and visceral adipose tissue were measured by real-time PCR and Western blot.The statistical analyses were performed using the SPSS 13.0 software package,and the significance of differences between groups was analyzed by one-way ANOVA.Results The glucose consumption of human visceral preadipocytes in group H-T ((5.6 ± 1.6) mmol/L) and H-P ((4.4 ± 1.6) mmol/L) were higher than that in group H-N ((2.0 ± 0.8) mmol/L).The 60-120 min glucose infusion rates in euglycaemichyperinsulinaemic clamp test were (18± 5) and (20 ±4) mg· kg-1 · min-1 in group O-T and O-P,Prespectively,which were both higher than that of group O-HFD((10 ± 3) mg · kg-1 · min-1,F =8.136,P ＜ 0.05).That improvement was also manifested with the HOMA index of insulin resistance in OGTT of OLETF rats (F =5.784,P ＜ 0.05).Telmisartan reduced the abdominal circumference ((24.0 ± 2.0) vs (26.5 ± 2.7) cm),visceral fat tissue coefficient (5.8％ ±2.4％ vs 8.6％ ±2.4％),serum free fatty acids ((2.8 ±0.7) vs (5.3 ± 1.8) μg/L) and the fasting plasma glucose ((10 ±6)vs(15 ±7) mmol/L)in high-fat-diet OLETF rats (P ＜ 0.05).The mRNA and proteinexpression of adiponectin in human preadipocytes and the adipose tissue in OLETF rats were up-regulated significantly by telmisartan (P ＜ 0.05).The especially important result was that the mRNA and protein expression of adiponectin in the human visceral preadipocytes and the OLEFF rats visceral adipose tissue were higher in group H-T and group O-T than those in group H-P and O-P(59.9 ± 2.0 vs 6.0 ± 1.6,1.807 ± 0.297 vs 1.332 ± 0.112,4.43 ±2.57 vs 1.71 ±0.57,2.6±0.9 vs 1.9 ±0.5,with all P＜0.05).Conclusions Telmisartan can increase the insulin sensitivity in the high-fat-diet OLETF rats and the human preadipocytes,ameliorate the visceral obesity and improve the glucose and lipid metabolism in the OLETF rats Those effects might via the upregulation of adiponectin expression in the adipose tissue,especially in the visceral adipose tissue.